Free equity investment tool of Japanese companies

Financial Statement Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

日本ユニシス

VITAL KSK HOLDINGS

Forest Holdings

TOHO PHARMACEUTICAL

Shinko Shoji

JFE SHOJI TRADE

shoeifoods

Naito

CENTRAL AUTOMOTIVE PRODUCTS

神戸物産

AINAVO HOLDINGS

TOTECH

オーハシテクニカ

KONISHI

加藤産業

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

10/30 Real Estate (DAIBIRU:BBB→A e..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Hitachi Zosen etc.

NIPPON COKE & ENGINEERING

メルコホールディングス

ROHM

日本セラミック etc.

Financial Statement Details: TOHO PHARMACEUTICAL+Toshin Group (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Statement data

F/S Outline: TOHO PHARMACEUTICAL+Toshin Group (Annual )

Switch ViewU-ChartU-Chart and F/SF/S

Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2013-05-20)
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2013-03-31  *  Total: ¥ 562 B  *  Net: ¥ 134 B  (Ratio: 23.86%)	[BS] 2013-05-20  *  Total: ¥ 39 B  *  Net: ¥ 31 B  (Ratio: 80.49%)
Financial Statement Details	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2013-05-20)
Cash etc.	¥ 41 B	¥ 18 B
Other Current Assets	¥ 369 B	¥ 7 B
Tangible Assets	¥ 70 B	¥ 10 B
Intangible Assets	¥ 15 B	¥ 448 M
Investment etc.	¥ 65 B	¥ 2 B
Total Assets	¥ 562 B	¥ 39 B
Current Liabilities	¥ 393 B	¥ 6 B
Fixed Liabilities	¥ 34 B	¥ 1 B
Capital stock	¥ 10 B	¥ 865 M
Capital surplus etc.	¥ 123 B	¥ 30 B
Liabilities and net assets	¥ 562 B	¥ 39 B
Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2013-05-20)
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2013-03-31  *  Sales: ¥ 1.1 T  *  Income: ¥ 11 B  (Ratio: 1.01%)	[PL] 2013-05-20  *  Sales: ¥ 43 B  *  Income: ¥ 1 B  (Ratio: 4.57%)
Financial Statement Details	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2013-05-20)
Sales	¥ 1.1 T	¥ 43 B
Cost of Sales	¥ 1.0 T	¥ 34 B
Gross profit	¥ 102 B	¥ 9 B
Other income	¥ 8 B	¥ 952 M
SG&A	¥ 86 B	¥ 6 B
Other expenses	¥ 12 B	¥ 1 B
Net income	¥ 11 B	¥ 1 B
Consolidated :Cash flow statement (C/F) Consolidated | Non-Consolidated | Small | Large
U-Chart	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2013-05-20)
Operating CF Investment CF Financial CF Foreign Exchange Effects Net Change in Cash	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
	[CF] 2013-03-31  *  OCF: ¥ 24 B  *  Cash: ¥ -1 B	[CF] 2013-05-20  *  OCF: ¥ 2 B  *  Cash: ¥ +1 B
Financial Statement Details	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2013-05-20)
Operating CF	¥ 24 B	¥ 2 B
Investment CF	¥ -10 B	¥ -59 M
Financial CF	¥ -15 B	¥ -1 B
Foreign Exchange Effects	¥ 203 M	-
Net Change in Cash	¥ -1 B	¥ 1 B
Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2013-05-20)
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2013-03-31  *  Income: ¥ 11 B  *  Net: ¥ +12 B	[SS] 2013-05-20  *  Income: ¥ 1 B  *  Net: ¥ +852 M
Financial Statement Details	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2013-05-20)
Issuance of new shares	-	-
Dividends from surplus	¥ -1 B	¥ -262 M
Net income	¥ 11 B	¥ 1 B
Purchase of treasury stock	¥ -4 B	¥ -621 M
Other Change in Stockholders Equity	¥ 214 M	¥ -258 M
Other Change in Net Assets	¥ 7 B	¥ 17 M
Net Change in Net Assets	¥ 12 B	¥ 852 M

Non-Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2011-05-20)
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2013-03-31  *  Total: ¥ 127 B  *  Net: ¥ 86 B  (Ratio: 67.79%)	[BS] 2011-05-20  *  Total: ¥ 35 B  *  Net: ¥ 29 B  (Ratio: 83.40%)
Financial Statement Details	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2011-05-20)
Cash etc.	¥ 5 B	¥ 13 B
Other Current Assets	¥ 12 B	¥ 8 B
Tangible Assets	¥ 34 B	¥ 9 B
Intangible Assets	¥ 249 M	¥ 473 M
Investment etc.	¥ 75 B	¥ 3 B
Total Assets	¥ 127 B	¥ 35 B
Current Liabilities	¥ 18 B	¥ 5 B
Fixed Liabilities	¥ 22 B	¥ 774 M
Capital stock	¥ 10 B	¥ 865 M
Capital surplus etc.	¥ 75 B	¥ 28 B
Liabilities and net assets	¥ 127 B	¥ 35 B
Non-Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2011-05-20)
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2013-03-31  *  Sales: ¥ 6 B  *  Income: ¥ 4 B  (Ratio: 79.68%)	[PL] 2011-05-20  *  Sales: ¥ 42 B  *  Income: ¥ 2 B  (Ratio: 4.87%)
Financial Statement Details	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2011-05-20)
Sales	¥ 6 B	¥ 42 B
Cost of Sales	¥ 2 B	¥ 37 B
Gross profit	¥ 3 B	¥ 5 B
Other income	¥ 2 B	¥ 970 M
SG&A	-	¥ 2 B
Other expenses	¥ 844 M	¥ 1 B
Net income	¥ 4 B	¥ 2 B
Non-Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2011-05-20)
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2013-03-31  *  Income: ¥ 4 B  *  Net: ¥ +4 B	[SS] 2011-05-20  *  Income: ¥ 2 B  *  Net: ¥ +728 M
Financial Statement Details	TOHO PHARMACEUTICAL (2013-03-31)	Toshin Group (2011-05-20)
Issuance of new shares	-	-
Dividends from surplus	¥ -1 B	¥ -267 M
Net income	¥ 4 B	¥ 2 B
Purchase of treasury stock	¥ -4 B	¥ -814 M
Other Change in Stockholders Equity	¥ 8 M	¥ -275 M
Other Change in Net Assets	¥ 6 B	¥ 1 M
Net Change in Net Assets	¥ 4 B	¥ 728 M

Related Information: TOHO PHARMACEUTICAL  Toshin Group 

Statement Type

Annual : TOHO PHARMACEUTICAL+Toshin Group

First quarter : TOHO PHARMACEUTICAL+Toshin Group

Second quarter : TOHO PHARMACEUTICAL+Toshin Group

Third quarter : TOHO PHARMACEUTICAL+Toshin Group

Analysis Menu

Outline : TOHO PHARMACEUTICAL+Toshin Group

Statement : TOHO PHARMACEUTICAL+Toshin Group

Rating : TOHO PHARMACEUTICAL+Toshin Group

Indicator : TOHO PHARMACEUTICAL+Toshin Group

Download : TOHO PHARMACEUTICAL+Toshin Group

Industry Comparison Ranking

Wholesale Trade - EDIUNET Industry Rankings

Wholesale Trade - EDIUNET Credit Rating

Wholesale Trade - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo世田谷区 - EDIUNET Prefectures

Tokyo新宿区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/20	リーバイ・ストラウス　..	C	2013-11-30
1/20	TIEMCO	BB	2013-11-30
1/15	イワキ	BBB	2013-11-30
1/15	マルカキカイ	BBB	2013-11-30
1/15	ALTECH	BB	2013-11-30
1/15	Shinwa	BBB	2013-11-30 (Q1)
1/15	ONWARD HOLDINGS	A	2013-11-30 (Q3)
1/15	ガリバーインターナショ..	BBB	2013-11-30 (Q3)
1/15	Morito	A	2013-11-30
1/15	BIKE O	BB→BBB	2013-11-30

EDIUNET Investment News (Wholesale Trade)

1/20 Wholesale Trade (リーバイ・..

1/15 Wholesale Trade (イワキ:BBB ..

1/10 Wholesale Trade (エコーＴＤ:..

1/9 Wholesale Trade (KITAKEI:BBB)

1/8 Wholesale Trade (F&A AQUA HO..

1/7 Wholesale Trade (Wakita:A)

1/6 Wholesale Trade (ADVAN:AA)

12/27 Wholesale Trade (ADVANCE:CC ..

12/26 Wholesale Trade (NAGAILEBEN:..

. Wholesale Trade (OOMITSU CO...

Company Information

Ticker	Market	Industry	Month	report	Rating
TOHO PHARMACEUTICAL	8129	TSE 1st	Wholesale Trade	3	Annual	BBB
Toshin Group	2761	OSE JASDAQ	Wholesale Trade	5	Annual	AA

Related Company

日本ユニシス (Sales ¥ 269 B)

SUGITA ACE (Sales ¥ 45 B)

Shinko Shoji (Sales ¥ 154 B)

DAIICHI JITSUGYO (Sales ¥ 128 B)

Morito (Sales ¥ 33 B)

TOTECH (Sales ¥ 66 B)

加藤産業 (Sales ¥ 733 B)

KONISHI (Sales ¥ 104 B)

SUZUKEN (Sales ¥ 1.8 T)

Toshin Group (Sales ¥ 43 B)

Naito (Sales ¥ 35 B)

ONOKEN. (Sales ¥ 149 B)

Elematec (Sales ¥ 129 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .